Treatment of Chalazia
Start with warm compresses (5-10 minutes, 3-4 times daily) combined with eyelid hygiene as first-line treatment for all chalazia, and if there's no improvement after 4-6 weeks, proceed to intralesional triamcinolone acetonide injection before considering surgery. 1, 2
Initial Conservative Management (First 4-6 Weeks)
The American Academy of Ophthalmology recommends a stepwise approach beginning with conservative measures:
- Apply warm compresses to the affected eyelid for 5-10 minutes, 3-4 times daily to promote drainage of the obstructed meibomian gland 1, 2
- Perform gentle massage of the affected area immediately after warm compresses to help express the obstructed gland 1, 2
- Institute eyelid hygiene by cleaning the eyelid margins with mild soap or commercial eyelid cleansers 1, 2
Critical timing caveat: Do not continue conservative management beyond 4-6 weeks without reevaluation, as prolonging treatment may delay diagnosis of sebaceous carcinoma, particularly in older patients 1, 2
Treatment Escalation for Persistent Chalazia
Second-Line: Intralesional Steroid Injection
- Inject triamcinolone acetonide directly into the lesion as the next step for chalazia persisting after 4-6 weeks of conservative therapy 1, 2
- This approach achieves resolution in approximately 88% of non-infected cases, often with a single injection 3
- Re-evaluate within a few weeks after injection to assess response and check intraocular pressure 2
- Steroid injection is particularly suitable for:
Third-Line: Surgical Intervention
- Incision and curettage is indicated when steroid injection fails or for infected chalazia 3, 4
- Combined incision, curettage, and intralesional steroid injection achieves 100% resolution and is most effective for large, recurrent, or multiple chalazia 4
Addressing Underlying Conditions (Essential for Prevention)
Before treating the chalazion itself, address predisposing factors:
- Treat any associated bacterial blepharitis or meibomian gland dysfunction, as these are common predisposing factors 1, 2
- Evaluate for meibomian gland dysfunction, rosacea, or seborrheic dermatitis in patients with recurrent chalazia 1, 2
- Consider systemic antibiotics for severe underlying blepharitis 2
- Maintain regular eyelid hygiene for patients prone to recurrence 1, 2
Critical Red Flags: When to Biopsy
Always biopsy in these situations to exclude sebaceous carcinoma:
- Recurrent chalazia in the same location, especially in elderly patients 1, 2, 5
- Chalazia with marked asymmetry or resistance to standard therapy 1, 2
- Atypical features including eyelid margin distortion, focal lash loss, or ulceration 2
- Unilateral chronic blepharitis unresponsive to therapy 2
This is the most critical pitfall to avoid—prolonging treatment without considering malignancy in high-risk presentations 1
Emerging Treatment Options
- Intense pulsed light (IPL) with meibomian gland expression shows promise for multiple recurrent chalazia resistant to conventional therapy 1, 2, 5
- Use IPL with caution in individuals with darker skin pigmentation (Fitzpatrick type IV or above) due to risk of burns and pigmentation changes 1
Pediatric Considerations
- Children with chalazia should be evaluated for chronic blepharokeratoconjunctivitis, which often presents with recurrent conjunctivitis, keratitis, neovascularization, and eyelid inflammation 1, 2
- Refer to ophthalmology if there is visual loss, moderate/severe pain, or severe/chronic redness 2
- Intralesional steroid injection is particularly well-suited for pediatric patients as it avoids general anesthesia 3, 4